Nurix Therapeutics’s Return On Capital Employed Insights
Benzinga Pro data, Nurix Therapeutics (NASDAQ:NRIX) reported Q2 sales of $11.43 million. Earnings fell to a loss of $45.40 million, resulting in a 6.74% decrease from last quarter.
Kura Sushi USA’s Return On Capital Employed Insights
According to Benzinga Pro, during Q3, Kura Sushi USA (NASDAQ:KRUS) earned $477.00 thousand, a 125.39% increase from the preceding quarter. Kura Sushi USA also posted a total of $37.97 million in sales, a 21.35% increase since Q2.
Byrna Technologies’s Return on Invested Capital Overview
According to Benzinga Pro data, during Q2, Byrna Technologies (NASDAQ:BYRN) posted sales of $11.62 million. Earnings were up 6.99%, but Byrna Technologies still reported an overall loss of $3.00 million.
WD-40’s Return on Invested Capital Insights
Pulled from Benzinga Pro data, WD-40 (NASDAQ:WDFC) posted Q3 earnings of $14.48 million, an increase from Q2 of 25.77%. Sales dropped to $123.67 million, a 4.86% decrease between quarters.
RVL Pharma Issues Interim Q2 Sales From Its Droopy Eye Treatment
RVL Pharmaceuticals plc (NASDAQ:RVLP) announced preliminary Q2 FY22 sales from Upneeq of $8.4 million, up 42% sequentially. Upneeq (oxymetazoline hydrochloride…
Why U.S. Stock Futures Are Down Ahead Of Key Jobs Report For June
Pre-open movers
U.S. stock futures traded lower in early pre-market trade on Thursday ahead of the much-awaited jobs report for June.
GameStop, Levi Strauss And 3 Stocks To Watch Heading Into Friday
With US stock futures trading lower this morning on Friday ahead of the much-awaited jobs report for June, some of the stocks that may grab investor focus today are as follows:
Nurix Therapeutics Q2 EPS $(1.01) Down From $(0.60) YoY
Nurix Therapeutics (NASDAQ:NRIX) reported quarterly losses of $(1.01) per share. This is a 68.33 percent decrease over losses of $(0.60) per share from the same period last year.
WD-40 Q3 EPS $1.07 Misses $1.27 Estimate, Sales $123.67M Miss $142.77M Estimate
WD-40 (NASDAQ:WDFC) reported quarterly earnings of $1.07 per share which missed the analyst consensus estimate of $1.27 by 15.75 percent. This is a 29.61 percent decrease over earnings of $1.52 per share from the same
Kura Sushi USA Q3 EPS $0.05 Beats $(0.10) Estimate, Sales $38.00M Beat $35.54M Estimate
Kura Sushi USA (NASDAQ:KRUS) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $(0.10) by 150 percent. This is a 109.26 percent increase over losses of $(0.54) per share from the